Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study

Familial predisposition is a strong risk factor for different types of cancer and accounts for around 10% of the cases. In this study, we investigated cancer predisposition in a Palestinian family using whole-exome sequencing (WES) technologies. In this study, we focused more on cutaneous melanoma (...

Full description

Bibliographic Details
Main Authors: Eman Fares, Rua Thawabtah, Husam Sallam, Areej A. H. Khatib, Nouar Qutob, Zaidoun Salah
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1230241/full
_version_ 1797644654918762496
author Eman Fares
Rua Thawabtah
Husam Sallam
Areej A. H. Khatib
Nouar Qutob
Zaidoun Salah
author_facet Eman Fares
Rua Thawabtah
Husam Sallam
Areej A. H. Khatib
Nouar Qutob
Zaidoun Salah
author_sort Eman Fares
collection DOAJ
description Familial predisposition is a strong risk factor for different types of cancer and accounts for around 10% of the cases. In this study, we investigated cancer predisposition in a Palestinian family using whole-exome sequencing (WES) technologies. In this study, we focused more on cutaneous melanoma (CM). Our analysis identified three heterozygous rare missense variants, WRN (p.L383F and p.A995T) and TYRP1 (p.T262M) and a pathogenic homozygous missense mutation in ERCC2 (p.R683Q). Although WRN and TYRP1 genes and their variations were correlated with different types of cancer, including melanoma, the currently identified WRN and TYRP1 variants were not reported previously in melanoma cases. The pathogenic mutation was segregated with the clinical phenotypes and found in the two affected brothers, one with CM and the other with brain tumor, and was confirmed by Sanger sequencing analysis. Segregation analysis of this mutation revealed that family members are either heterozygous or wild type. Our findings confirm that the homozygous ERCC2 (p.R683Q) mutation was responsible for causing melanoma and other cancer types in the family. Our work highlights the value to decipher the mutational background of familial cancers, especially CM, in the Palestinian population to guide diagnosis, prevention, and treatment of affected patients and their families.
first_indexed 2024-03-11T14:33:42Z
format Article
id doaj.art-d38c2561c01f49c3a70a3844919e4bc4
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-11T14:33:42Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-d38c2561c01f49c3a70a3844919e4bc42023-10-31T05:49:59ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-10-011410.3389/fgene.2023.12302411230241Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing studyEman Fares0Rua Thawabtah1Husam Sallam2Areej A. H. Khatib3Nouar QutobZaidoun SalahHealth Sciences Department, Faculty of Graduate Studies, Arab American University, Ramallah, PalestineHealth Sciences Department, Faculty of Graduate Studies, Arab American University, Ramallah, PalestineHealth Sciences Department, Faculty of Graduate Studies, Arab American University, Ramallah, PalestineWomen Health Research Unit, McGill University Health Center, Montreal, QC, CanadaFamilial predisposition is a strong risk factor for different types of cancer and accounts for around 10% of the cases. In this study, we investigated cancer predisposition in a Palestinian family using whole-exome sequencing (WES) technologies. In this study, we focused more on cutaneous melanoma (CM). Our analysis identified three heterozygous rare missense variants, WRN (p.L383F and p.A995T) and TYRP1 (p.T262M) and a pathogenic homozygous missense mutation in ERCC2 (p.R683Q). Although WRN and TYRP1 genes and their variations were correlated with different types of cancer, including melanoma, the currently identified WRN and TYRP1 variants were not reported previously in melanoma cases. The pathogenic mutation was segregated with the clinical phenotypes and found in the two affected brothers, one with CM and the other with brain tumor, and was confirmed by Sanger sequencing analysis. Segregation analysis of this mutation revealed that family members are either heterozygous or wild type. Our findings confirm that the homozygous ERCC2 (p.R683Q) mutation was responsible for causing melanoma and other cancer types in the family. Our work highlights the value to decipher the mutational background of familial cancers, especially CM, in the Palestinian population to guide diagnosis, prevention, and treatment of affected patients and their families.https://www.frontiersin.org/articles/10.3389/fgene.2023.1230241/fullcutaneous melanoma, xeroderma pigmentosumNERPalestinian familyERCC2/XPDcancer syndrome
spellingShingle Eman Fares
Rua Thawabtah
Husam Sallam
Areej A. H. Khatib
Nouar Qutob
Zaidoun Salah
Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
Frontiers in Genetics
cutaneous melanoma, xeroderma pigmentosum
NER
Palestinian family
ERCC2/XPD
cancer syndrome
title Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
title_full Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
title_fullStr Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
title_full_unstemmed Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
title_short Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study
title_sort genomic analysis of a palestinian family with inherited cancer syndrome a next generation sequencing study
topic cutaneous melanoma, xeroderma pigmentosum
NER
Palestinian family
ERCC2/XPD
cancer syndrome
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1230241/full
work_keys_str_mv AT emanfares genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy
AT ruathawabtah genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy
AT husamsallam genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy
AT areejahkhatib genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy
AT nouarqutob genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy
AT zaidounsalah genomicanalysisofapalestinianfamilywithinheritedcancersyndromeanextgenerationsequencingstudy